Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

January 1, 2018

Study Completion Date

October 10, 2018

Conditions
Burning Nose
Interventions
DRUG

Midazolam

Patients received 0.5 mg/kg midazolam, with a maximum dose of 10 mg, Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.

DRUG

Lidocaine-Midazolam

Patients received a puff of lidocaine 2% in each nostril, after 60 seconds, they received 0.5 mg/kg midazolam, with a maximum dose of 10 mg. , Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.

DRUG

Placebo

Patients received saline 9% (placebo), 0.5 mg/kg, with a maximum dose of 10 mg, Immediately following the administration, the child was asked to record the score of pain on the self reporting pain scale, WBFS.

Trial Locations (1)

Unknown

Tishreen University, Latakia

All Listed Sponsors
lead

Tishreen University

OTHER

NCT03725995 - Using Intranasal Midazolam (INM) and Lidocaine for Uncooperative Children | Biotech Hunter | Biotech Hunter